IP Library › Granted Patent US 11,571,379
Granted Patent B2
US 11,571,379 · App. 17/155,151 · Granted Feb 7, 2023

Skin care composition

Inventors: Tomohiro Hakozaki (Cincinnati, OH); Bin Fang Deyer (Loveland, OH)
Assignee: The Procter & Gamble Company
A61K8/73A61K8/062A61K8/671A61K8/675A61K8/678A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,571,379
App. No.
17/155,151
Granted
Feb 7, 2023
Kind
B2
Abstract

Methods and compositions for improving the appearance of skin are provided. The methods and compositions are especially suited for improving sallow-looking skin by enhancing bilirubin degradation in skin. The methods and compositions herein utilize one or more sucrose esters, which demonstrate a surprising ability to reduce bilirubin levels. The method involves applying a skin care composition containing an effective amount of a sucrose ester to a target portion of skin where a reduction in bilirubin level is desired.

Claims (21)

1. A skin care composition, comprising:

a) an effective amount of sucrose ester comprising sucrose laurate and sucrose dilaurate at a ratio of sucrose laurate to sucrose dilaurate ranging from about 3:1 to about 3:2 wherein the effective amount of sucrose ester reduces yellowness levels according to a b* assay by at least 10% relative to a vehicle control containing the dermatologically acceptable carrier without sucrose ester; and

b) a dermatologically acceptable carrier.

2. The skin care composition of claim 1 , wherein the sucrose ester is present at about 0.001% to about 10% by weight of the composition.

3. The skin care composition of claim 1 , wherein the composition further comprises at least one additional ingredient selected from vitamins, minerals, peptides, sugar amines, sunscreen agents, oil control agents, flavonoid compounds, anti-oxidants, preservatives, protease inhibitors, tyrosinase inhibitors, anti-inflammatory agents, moisturizing agents, exfoliating agents, skin lightening agents, lubricants, anti-acne actives, chelating agents, anti-wrinkle actives, anti-atrophy actives, phytosterols, N-acyl amino acid compounds, antimicrobials, and antifungals, conditioning agents, emulsifiers, rheology modifiers, and combinations thereof.

4. The skin care composition of claim 3 , wherein the additional ingredient is selected from vitamin B3 compounds, vitamin E compounds, peptides, retinoids, and combinations thereof.

5. The skin care composition of claim 3 , wherein the additional ingredient includes a rheology modifier selected from sodium polyacrylate superabsorbent polymers, starch grafted sodium polyacrylate superabsorbent polymers, and combinations thereof.

6. The skin care composition of claim 1 , further comprising at least about 10% of a silicone fluid.

7. The skin care composition of claim 1 , wherein the skin care composition is an oil-in-water emulsion.

8. The skin care composition of claim 7 , further comprising a non-ionic emulsifier.

9. A method of degrading bilirubin in skin, comprising:

a) identifying a target portion of skin where treatment is desired; and

b) applying the skin care composition of claim 1 to the target portion of skin, wherein the effective amount of sucrose ester reduces yellowness levels over the course of a treatment period.

10. The method of claim 9 , wherein the composition comprises about 0.001% to about 10% sucrose ester, by weight.

11. The method of claim 9 , wherein the target portion of skin exhibits a sign of bilirubin accumulation.

12. The method of claim 9 , wherein the effective amount of sucrose ester reduces b* value by at least 10% relative to the vehicle control, according to the b* assay.

13. The method of claim 9 , wherein the effective amount of sucrose ester reduces yellowness levels by at least 10% relative to a positive control of 80% (v/v) bilirubin in dimethyl sulfoxide, according to the b* assay.

14. The method of claim 9 , wherein the treatment period is at least 2 weeks.

15. The method of claim 9 , wherein the composition includes at least about 10% of a silicone fluid.

16. The method of claim 9 , wherein the composition further comprises at least one additional ingredient selected from vitamins, minerals, peptides, sugar amines, sunscreen agents, oil control agents, flavonoid compounds, anti-oxidants, preservatives, protease inhibitors, tyrosinase inhibitors, anti-inflammatory agents, moisturizing agents, exfoliating agents, skin lightening agents, lubricants, anti-acne actives, chelating agents, anti-wrinkle actives, anti-atrophy actives, phytosterols, N-acyl amino acid compounds, antimicrobials, and antifungals, conditioning agents, emulsifiers, rheology modifiers, and combinations of these.

17. The method of claim 16 , wherein the additional ingredient is selected from vitamin B3 compounds, vitamin E compounds, peptides, retinoids, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2021
From: HAKOZAKI, TOMOHIRO (NMN); FANG DEYER, BIN (NMN)
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 056309/0640 →
Continuity (2)
Provisional Application 62965189 · Jan 24, 2020
Related Publication 20210228469A1 · Jul 29, 2021
Cited By (1)
US 12,599,548